Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.490
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
1.500
+0.010 (0.67%)
After-hours: May 12, 2025, 7:38 PM EDT
Evaxion Biotech Employees
Evaxion Biotech had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.
Employees
46
Change (1Y)
-3
Growth (1Y)
-6.12%
Revenue / Employee
$72,696
Profits / Employee
-$229,717
Market Cap
9.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVAX News
- 14 days ago - 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting - GlobeNewsWire
- 4 weeks ago - Evaxion to present at World Vaccine Congress - GlobeNewsWire
- 5 weeks ago - Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Evaxion to announce business update and full year 2024 financial results on April 1, 2025 - GlobeNewsWire
- 6 weeks ago - Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting - GlobeNewsWire
- 2 months ago - Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package - GlobeNewsWire
- 3 months ago - Evaxion announces closing of $10.8 million public offering - GlobeNewsWire
- 3 months ago - Evaxion announces pricing of $10.8 million public offering - GlobeNewsWire